Avista Pharma Solutions Revenue, Growth & Competitor Profile

DBA ACCURATUS LAB SERVICES, INC.
DBA ATS LABS
DBA CAMBREX

Company Profile & Annual Report for Avista Pharma Solutions

Access the complete profile.

Avista Pharma Solutions Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	54138 Testing Laboratories
Additional NAICS Codes	5417 Scientific Research & Development Services
Address	3501 Tricenter Blvd Ste C Durham, NC 27713

Note: Revenues for privately held companies are statistical evaluations.


Avista Pharma Solutions's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Avista Pharma Solutions's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Avista Pharma Solutions is classified as operating in the Testing Laboratories industry, NAICS Code 54138.

Avista Pharma Solutions Annual Revenue and Growth Rate

Avista Pharma Solutions	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Avista Pharma Solutions's revenues are gauged from an analysis of company filings.

Avista Pharma Solutions's Income Statement (based on Industry Averages)

Avista Pharma Solutions P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Avista Pharma Solutions is developing and marketing. Avista Pharma Solutions doesn't have any recent trademark applications, indicating Avista Pharma Solutions is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
SUCCESS BEYOND SCIENCE Early to late phase drug manufacturing services for others; and manufacturing of drug substances and custom synthesis for new or transferred substances for others	01/15/2018

See all trademarks and details in the Full Report.

Market Share of Avista Pharma Solutions's Largest Competitors

A competitive analysis shows these companies are in the same general field as Avista Pharma Solutions, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
EUROFINS SCIENTIFIC	Des Moines, IA	100
INTERTEK USA	Houston, TX	44
UL	Northbrook, IL	39
PACE ANALYTICAL SERVICES	Minneapolis, MN	33
TECHCORR USA MANAGEMENT	Pasadena, TX	20
FOOD SAFETY NET SERVICES	San Antonio, TX	16
APPLIED TECHNICAL SERVICES	Marietta, GA	11
ALLIANCE SOURCE TESTING	Decatur, AL	10
IRISNDT	Houston, TX	10

Nearby Competitors

These companies are similar in business line and location to Avista Pharma Solutions. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
AVISTA PHARMA SOLUTIONS	Durham, NC	100
CORONADO VENTURES	Durham, NC	43
THREE OAKS ENGINEERING	Durham, NC	27
DUDA/PAINE ARCHITECTS P.A.	Durham, NC	24
MHAWORKS P.A.	Durham, NC	24
O'BRIEN/ATKINS ASSOCIATES P.A.	Rtp, NC	17

Future Competition: Avista Pharma Solutions's Fastest Growing Competitors

These companies are in the same general field as Avista Pharma Solutions and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)